A client with hepatic encephalopathy receives lactulose. Which finding indicates that the current regimen requires prompt follow-up?
1No bowel movement for 48 hours with unchanged confusion✓ Correct answer
2Two soft stools today with improved attention and orientation
3Three soft stools today with reduced asterixis and clearer speech
4Two soft stools today with improved sleep-wake pattern
Explanation
Lactulose for hepatic encephalopathy is titrated to produce 2 or 3 soft stools each day while mental status improves. No bowel movement for 48 hours with persistent confusion suggests inadequate effect and requires prompt reassessment of administration, bowel function, and the treatment plan. Two or three soft stools with neurologic improvement reflect the therapeutic goal. Excessive diarrhea would also require follow-up because it can cause fluid and electrolyte loss.
Clinical reasoning Lactulose traps ammonia in the colon and increases its elimination. The bedside response is judged by both stool frequency and improvement in encephalopathy.
Decision rule Aim for 2 or 3 soft stools daily, reassess inadequate stool output or persistent confusion, and avoid excessive diarrhea.
Scenario 62-year-old male with cirrhosis and hepatic encephalopathy on lactulose 30 mL PO TID. Baseline ammonia 110, confusion grade 2.
Lactulose — A nonabsorbable disaccharide that acidifies colonic contents and promotes ammonia elimination in hepatic encephalopathy.
Hepatic encephalopathy — Reversible neurologic dysfunction caused by liver failure and toxin accumulation, monitored through mental status and other neurologic findings.
Rifaximin add-on — Non-absorbable antibiotic added to lactulose to reduce recurrent encephalopathy.